172@29@17@107!~!172@29@0@53!~!|news|business|earnings|strides-pharma-consolidated-december-2019-net-sales-at-rs-732-44-crore-down-7-81-y-o-y-2-4884811.html?utm_source=MC_OpeninApp!~!|controller|infinite_scroll_article.php
Moneycontrol
Financial Freedom Offer: Subscribe to Moneycontrol Pro and grab benefits worth ₹15,000/-
Last Updated : Jan 31, 2020 11:22 AM IST | Source: Moneycontrol.com

Strides Pharma Consolidated December 2019 Net Sales at Rs 732.44 crore, down 7.81% Y-o-Y

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Consolidated quarterly numbers for Strides Pharma Science are:

Net Sales at Rs 732.44 crore in December 2019 down 7.81% from Rs. 794.50 crore in December 2018.

Quarterly Net Profit at Rs. 93.89 crore in December 2019 down 68% from Rs. 293.42 crore in December 2018.

Close

EBITDA stands at Rs. 194.49 crore in December 2019 up 52.04% from Rs. 127.92 crore in December 2018.

Strides Pharma EPS has decreased to Rs. 10.48 in December 2019 from Rs. 32.77 in December 2018.

Strides Pharma shares closed at 468.85 on January 30, 2020 (NSE) and has given 26.32% returns over the last 6 months and -1.67% over the last 12 months.

Strides Pharma Science
Consolidated Quarterly Resultsin Rs. Cr.
Dec'19Sep'19Dec'18
Net Sales/Income from operations732.44715.09794.50
Other Operating Income------
Total Income From Operations732.44715.09794.50
EXPENDITURE
Consumption of Raw Materials277.54257.99196.67
Purchase of Traded Goods38.8333.54162.40
Increase/Decrease in Stocks-55.297.3723.65
Power & Fuel------
Employees Cost111.64109.70106.02
Depreciation43.4742.0040.67
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses177.45158.82178.67
P/L Before Other Inc., Int., Excpt. Items & Tax138.80105.6786.42
Other Income12.2212.990.83
P/L Before Int., Excpt. Items & Tax151.02118.6687.25
Interest39.6340.4250.09
P/L Before Exceptional Items & Tax111.3978.2437.16
Exceptional Items15.6383.440.74
P/L Before Tax127.02161.6837.90
Tax11.307.386.33
P/L After Tax from Ordinary Activities115.72154.3031.57
Prior Year Adjustments------
Extra Ordinary Items--8.86271.82
Net Profit/(Loss) For the Period115.72163.16303.39
Minority Interest1.560.81-3.01
Share Of P/L Of Associates-23.39-21.25-6.96
Net P/L After M.I & Associates93.89142.72293.42
Equity Share Capital89.5589.5589.55
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS10.4815.9432.77
Diluted EPS10.4815.9432.76
EPS After Extra Ordinary
Basic EPS10.4815.9432.77
Diluted EPS10.4815.9432.76
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

First Published on Jan 31, 2020 10:50 am
Sections